A Look At Tilray Brands (TLRY) Valuation After Recent Share Price Volatility

Simply Wall St.01-23

AdvertisementTilray Brands: recent performance snapshot Tilray Brands (TLRY) has drawn investor attention after a 5.3% gain over the past day, which contrasts with weaker returns over the week, month,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2605006449?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","is_english":true,"pubTime":"2026-01-23 06:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2605006449","market":"nz","top_or_hot":-1,"title":"A Look At Tilray Brands (TLRY) Valuation After Recent Share Price Volatility","media":"Simply Wall St.","content":"<div>\n<p>AdvertisementTilray Brands: recent performance snapshot Tilray Brands (TLRY) has drawn investor attention after a 5.3% gain over the past day, which contrasts with weaker returns over the week, month,...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tlry/tilray-brands/news/a-look-at-tilray-brands-tlry-valuation-after-recent-share-pr\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Look At Tilray Brands (TLRY) Valuation After Recent Share Price Volatility</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Look At Tilray Brands (TLRY) Valuation After Recent Share Price Volatility\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-23 06:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tlry/tilray-brands/news/a-look-at-tilray-brands-tlry-valuation-after-recent-share-pr><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AdvertisementTilray Brands: recent performance snapshot Tilray Brands (TLRY) has drawn investor attention after a 5.3% gain over the past day, which contrasts with weaker returns over the week, month,...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tlry/tilray-brands/news/a-look-at-tilray-brands-tlry-valuation-after-recent-share-pr\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DCF","symbol_name":"Dreyfus Alcentra Global Credit Income 2024 Target Term Fund, Inc","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tlry/tilray-brands/news/a-look-at-tilray-brands-tlry-valuation-after-recent-share-pr","article_id":"2605006449","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tlry/tilray-brands/news/a-look-at-tilray-brands-tlry-valuation-after-recent-share-pr","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2605006449","pubTimestamp":1769121135,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Tilray Brands: recent performance snapshot\nTilray Brands (TLRY) has drawn investor attention after a 5.3% gain over the past day, which contrasts with weaker returns over the week, month, and past 3 months and has prompted closer scrutiny of its recent share performance.\nSee our latest analysis for Tilray Brands.\nThat 5.3% 1 day share price gain comes after weaker momentum, including a 13.3% 30 day share price return and a 38.7% 90 day share price return. At the same time, the 1 year total...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"DCF":"Dreyfus Alcentra Global Credit Income 2024 Target Term Fund, Inc","BK4596":"哈里斯概念","BK4007":"制药","TLRY":"Tilray Inc.","BK4547":"WSB热门概念","BK4557":"大麻股"},"translate_title":"近期股价波动后看看Tilray Brands(TLRY)的估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DCF":1,"TLRY":1.5},"content_text":"AdvertisementTilray Brands: recent performance snapshot Tilray Brands (TLRY) has drawn investor attention after a 5.3% gain over the past day, which contrasts with weaker returns over the week, month, and past 3 months and has prompted closer scrutiny of its recent share performance. See our latest analysis for Tilray Brands. That 5.3% 1 day share price gain comes after weaker momentum, including a 13.3% 30 day share price return and a 38.7% 90 day share price return. At the same time, the 1 year total shareholder return of 18.5% and 3 year total shareholder return of 70.3% highlight how pressure on the stock has built over time. If Tilray’s recent swings have you reassessing the sector, it could be a good moment to widen your watchlist and look at broader healthcare stocks for comparison. With the share price under pressure over 1 and 3 years, yet trading below the average analyst price target and some intrinsic value estimates, you have to ask yourself: is Tilray underpriced here, or is the market already factoring in future growth? Price-to-Sales of 1.2x: Is it justified? On a simple P/S check, Tilray Brands trades at 1.2x sales, which sits well below peer and industry levels even after recent share price weakness. The P/S multiple compares the company’s market value to its revenue, which can be useful when earnings are negative or volatile, as they are for Tilray. For a business that is still loss making, revenue is one of the cleaner anchors investors often watch. Here, Tilray screens as “good value” at 1.2x sales compared with a peer average P/S of 11.7x and a US pharmaceuticals industry average P/S of 5x. Against an estimated fair P/S ratio of 1.7x, the current multiple also sits at a discount that the market could move toward if sentiment or fundamentals shift over time. Explore the SWS fair ratio for Tilray Brands Result: Price-to-sales of 1.2x (UNDERVALUED) However, the sizeable net loss of US$2,107.484m and the past 1-year total return decline of 18.5% could keep pressure on sentiment if progress stalls. Find out about the key risks to this Tilray Brands narrative. Another view using our DCF model Tilray also screens as “good value” on our DCF model, with the shares trading about 11.9% below an internal fair value estimate. That supports the 1.2x P/S signal. However, it raises a bigger question: how much weight do you place on models when the business is still loss making? Look into how the SWS DCF model arrives at its fair value. TLRY Discounted Cash Flow as at Jan 2026Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Tilray Brands for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 883 undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.  Build Your Own Tilray Brands Narrative If you look at the numbers and reach a different conclusion, or simply prefer to test your own view, you can build a custom thesis in just a few minutes with Do it your way. A great starting point for your Tilray Brands research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision. Ready for more investment ideas? If Tilray is on your radar, do not stop there. The real edge often comes from comparing a few different angles before you commit your capital.  Spot potential value by scanning these 883 undervalued stocks based on cash flows that currently trade below what their cash flows may suggest. Lean into future-facing themes by checking out these 24 AI penny stocks capturing attention in artificial intelligence. Target income-focused opportunities with these 13 dividend stocks with yields > 3% offering yields above 3%.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Tilray Brands might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.1","shortVersion":"4.36.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2605006449","isCrawlerRequest":true}